Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1

NCT00678886 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: otelixizumab infusion plus physician determined standard of care
BIOLOGICAL: placebo infusion plus physician determined standard of care

Sponsor

GlaxoSmithKline

Collaborators

[object Object]